Haw Par Corp Ltd (HAWPF)
7.03
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Haw Par Enterprise Value: -853.06M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 31, 2024 | -853.06M |
May 30, 2024 | -853.06M |
May 29, 2024 | -853.06M |
May 28, 2024 | -853.06M |
May 24, 2024 | -853.06M |
May 23, 2024 | -853.06M |
May 22, 2024 | -853.06M |
May 21, 2024 | -853.06M |
May 20, 2024 | -853.06M |
May 17, 2024 | -853.06M |
May 16, 2024 | -853.06M |
May 15, 2024 | -853.06M |
May 14, 2024 | -853.06M |
May 13, 2024 | -853.06M |
May 10, 2024 | -853.06M |
May 09, 2024 | -853.06M |
May 08, 2024 | -853.06M |
May 07, 2024 | -833.14M |
May 06, 2024 | -833.14M |
May 03, 2024 | -833.14M |
May 02, 2024 | -833.14M |
May 01, 2024 | -833.14M |
April 30, 2024 | -833.14M |
April 29, 2024 | -833.14M |
April 26, 2024 | -833.14M |
Date | Value |
---|---|
April 25, 2024 | -833.14M |
April 24, 2024 | -833.14M |
April 23, 2024 | -833.14M |
April 22, 2024 | -833.14M |
April 19, 2024 | -833.14M |
April 18, 2024 | -833.14M |
April 17, 2024 | -833.14M |
April 16, 2024 | -833.14M |
April 15, 2024 | -833.14M |
April 12, 2024 | -833.14M |
April 11, 2024 | -833.14M |
April 10, 2024 | -833.14M |
April 09, 2024 | -833.14M |
April 08, 2024 | -833.14M |
April 05, 2024 | -833.14M |
April 04, 2024 | -833.14M |
April 03, 2024 | -833.14M |
April 02, 2024 | -833.14M |
April 01, 2024 | -833.14M |
March 28, 2024 | -833.14M |
March 27, 2024 | -833.14M |
March 26, 2024 | -833.14M |
March 25, 2024 | -768.94M |
March 22, 2024 | -768.94M |
March 21, 2024 | -768.94M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-853.06M
Minimum
May 08 2024
98.80M
Maximum
Jul 02 2019
-428.19M
Average
-471.77M
Median
Sep 22 2022
Enterprise Value Benchmarks
WAVE Life Sciences Ltd | 575.88M |
ASLAN Pharmaceuticals Ltd | 17.82M |
EUDA Health Holdings Ltd | -- |
CytoMed Therapeutics Ltd | 18.45M |
Mobile-health Network Solutions | 45.39M |
Enterprise Value Related Metrics
Earnings Yield | 10.34% |
Operating Earnings Yield | 3.06% |
Normalized Earnings Yield | 10.34 |